Article Details

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Hold at ValuEngine

Retrieved on: 2019-03-28 11:11:15

Tags for this article:

Click the tags to see associated articles and topics

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Hold at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc boosted its position in Syndax Pharmaceuticals by 75.5% in the third quarter. <b>Sofinnova Ventures</b> Inc now owns 173,112 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up